GLOW 70 is a multi-peptide blend combining GHK-Cu, BPC-157, and TB500, developed to support preclinical research into mechanisms of tissue remodeling, cellular repair, and inflammatory modulation. The formulation brings together peptides that are actively studied in laboratory and non-clinical research settings for their complementary roles in regenerative and structural tissue investigations.

GLOW 70 is used in research contexts focused on peptide-based investigations. It is applied within laboratory and preclinical workflows examining tissue remodeling, cellular repair mechanisms, inflammatory pathways, and regenerative signaling processes.

Research involving this peptide combination focuses on molecular and cellular mechanisms rather than clinical outcomes. As such, side effects are not a defined endpoint within the scope of preclinical and laboratory research models.

GLOW 70 features a higher concentration of GHK-Cu alongside BPC-157 and TB500, offering an expanded platform for studying extracellular matrix regulation, collagen synthesis, angiogenic signaling, and cellular migration. This combination supports comprehensive investigation into synergistic peptide activity related to tissue integrity and repair.